RU2008132922A - METHOD FOR TREATING DAMAGES OF ORGANISM SYSTEMS DUE TO ACTIVATION OF THE PEROXIDATION PROCESS PROCESS AND THE LIQUID PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION - Google Patents
METHOD FOR TREATING DAMAGES OF ORGANISM SYSTEMS DUE TO ACTIVATION OF THE PEROXIDATION PROCESS PROCESS AND THE LIQUID PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION Download PDFInfo
- Publication number
- RU2008132922A RU2008132922A RU2008132922/14A RU2008132922A RU2008132922A RU 2008132922 A RU2008132922 A RU 2008132922A RU 2008132922/14 A RU2008132922/14 A RU 2008132922/14A RU 2008132922 A RU2008132922 A RU 2008132922A RU 2008132922 A RU2008132922 A RU 2008132922A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- composition according
- ethyl
- methyl
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract 15
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 15
- 238000000034 method Methods 0.000 title claims abstract 7
- 230000004913 activation Effects 0.000 title claims abstract 3
- 238000005502 peroxidation Methods 0.000 title claims abstract 3
- 239000004094 surface-active agent Substances 0.000 claims abstract 10
- IKMNOGHPKNFPTK-UHFFFAOYSA-N 2-ethyl-6-methylpyridin-1-ium-3-ol;4-hydroxy-4-oxobutanoate Chemical compound OC(=O)CCC(O)=O.CCC1=NC(C)=CC=C1O IKMNOGHPKNFPTK-UHFFFAOYSA-N 0.000 claims abstract 8
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract 8
- 239000003381 stabilizer Substances 0.000 claims abstract 7
- 239000002904 solvent Substances 0.000 claims abstract 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims abstract 4
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims abstract 2
- 230000003902 lesion Effects 0.000 claims abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract 2
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract 2
- 235000010265 sodium sulphite Nutrition 0.000 claims abstract 2
- 239000007921 spray Substances 0.000 claims abstract 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Способ лечения поражений систем организма, обусловленных активацией перекисного окисления, путем введения в организм раствора 2-этил-6-метил-3-гидроксипиридина сукцината, отличающийся тем, что 2-этил-6-метил-3-гидроксипиридина сукцинат вводят сублингвально в виде спрея, в дозе 100-300 мкл на 80 кг массы, содержащей 10-40 мг активного начала в 100 мг раствора. ! 2. Способ по п.1, отличающийся тем, что препарат вводят в течении 7-14 дней. ! 3. Жидкая фармацевтическая композиция, содержащая 2-этил-6-метил-3-гидроксипиридина сукцинат, растворитель и вспомогательные вещества, отличающаяся тем, что в качестве вспомогательных веществ она содержит поверхностно-активные вещества и сульфитный стабилизатор при следующих соотношениях ингредиентов, мас.%: ! 2-этил-6-метил-3-гидроксипиридина сукцинат10,0-40,0поверхностно-активные вещества0,1-10,0сульфитный стабилизатор0,1-1,0растворительостальное ! 4. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве растворителя она содержит водно-спиртовый раствор. ! 5. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве поверхностно-активного вещества она содержит полиэтиленгликоль. ! 6. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве поверхностно-активного вещества она содержит Твин 80. ! 7. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве поверхностно-активного вещества она содержит Твин 60. ! 8. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве сульфитного стабилизатора она содержит сульфит натрия. ! 9. Жидкая фармацевтическая композиция по п.2, отличающаяся тем, что в качестве сульфитного стаб1. A method of treating lesions of the body systems caused by the activation of peroxidation, by introducing into the body a solution of 2-ethyl-6-methyl-3-hydroxypyridine succinate, characterized in that 2-ethyl-6-methyl-3-hydroxypyridine succinate is administered sublingually into in the form of a spray, in a dose of 100-300 μl per 80 kg of mass containing 10-40 mg of active principle in 100 mg of solution. ! 2. The method according to claim 1, characterized in that the drug is administered within 7-14 days. ! 3. A liquid pharmaceutical composition containing 2-ethyl-6-methyl-3-hydroxypyridine succinate, a solvent and excipients, characterized in that it contains surfactants and a sulfite stabilizer as excipients in the following ratios of ingredients, wt.% :! 2-ethyl-6-methyl-3-hydroxypyridine succinate 10.0-40.0 surfactants 0.1-10.0 sulfite stabilizer 0.1-1.0 solvent 4. The liquid pharmaceutical composition according to claim 2, characterized in that it contains a water-alcohol solution as a solvent. ! 5. The liquid pharmaceutical composition according to claim 2, characterized in that it contains polyethylene glycol as a surfactant. ! 6. The liquid pharmaceutical composition according to claim 2, characterized in that it contains tween 80 as a surfactant.! 7. The liquid pharmaceutical composition according to claim 2, characterized in that it contains tween 60 as a surfactant.! 8. The liquid pharmaceutical composition according to claim 2, characterized in that it contains sodium sulfite as a sulfite stabilizer. ! 9. The liquid pharmaceutical composition according to claim 2, characterized in that as a sulfite stub
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008132922/14A RU2411034C2 (en) | 2008-08-12 | 2008-08-12 | Method of treating body system involvements caused by activated peroxidation process and liquid pharmaceutical composition for implementation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008132922/14A RU2411034C2 (en) | 2008-08-12 | 2008-08-12 | Method of treating body system involvements caused by activated peroxidation process and liquid pharmaceutical composition for implementation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008132922A true RU2008132922A (en) | 2010-02-20 |
| RU2411034C2 RU2411034C2 (en) | 2011-02-10 |
Family
ID=42126663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008132922/14A RU2411034C2 (en) | 2008-08-12 | 2008-08-12 | Method of treating body system involvements caused by activated peroxidation process and liquid pharmaceutical composition for implementation thereof |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2411034C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2527342C2 (en) * | 2012-08-03 | 2014-08-27 | Вадим Юрьевич Балабаньян | Sublingual form of 6-methyl-2-ethyl-3-hydroxypyridine and using it as agent possessing stimulating, anorectic, antidepressant, anxiolytic, antihypoxic, antiamnestic (nootropic), and antialcohol activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2205640C1 (en) * | 2002-04-09 | 2003-06-10 | Общество с ограниченной ответственностью "Экофарминвест" | Stable mexidol-containing pharmaceutical composition |
| RU2274464C2 (en) * | 2004-07-01 | 2006-04-20 | Общество с ограниченной ответственностью "Фирма "ВИПС-МЕД" | Composition used in treatment of diseases of mouth and nose cavity |
| UA28140U (en) * | 2007-07-23 | 2007-11-26 | Univ Nat Pharmaceutical | Use of mexidol as nephroprotective agent |
-
2008
- 2008-08-12 RU RU2008132922/14A patent/RU2411034C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2411034C2 (en) | 2011-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009126616A (en) | POWDER VALGANTSIKLOVIR | |
| JP2010536745A5 (en) | ||
| AR045193A1 (en) | FEXOFENADINE COMPOSITION AND PREPARATION PROCESS | |
| RU2008132922A (en) | METHOD FOR TREATING DAMAGES OF ORGANISM SYSTEMS DUE TO ACTIVATION OF THE PEROXIDATION PROCESS PROCESS AND THE LIQUID PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION | |
| RU2008140954A (en) | MEDICAL WIPES CONTAINING DESOXYRIBONUCLEASE AND LIPOSOMES FOR EXTERNAL USE | |
| AR033312A1 (en) | COMPOSITION THAT CONSISTS OF AN ADRENERGIC ALFA-2 AGONIST AND A FATTY ACID | |
| RU2008147790A (en) | PHARMACEUTICAL COMPOSITION BASED ON TILORONES OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT DESTRUCTIVE DISEASES OF MUCH AND SKIN, GENERAL DISEASES IN IMMUNO DEFICIENCY CONDITIONS | |
| RU2010129409A (en) | METHOD FOR TREATING RABBIT PSOROPTOSIS AND CARNIVOR ANIMAL OTODEKTOSIS | |
| RU2008147791A (en) | PHARMACEUTICAL COMPOSITION BASED ON CYCLOPHERON OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF PURULENT AND DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune Deficiency Conditions | |
| RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
| RU2008147792A (en) | PHARMACEUTICAL COMPOSITION BASED ON ACID ACIDONE ACID ACID AND ITS COMPOUNDS FOR TREATMENT OF PURULENT DESTRUCTIVE DISEASES OF Mucous and Skin, General Systemic Diseases in Immune-Deficient | |
| RU2015114709A (en) | STABLE INJECTION COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | |
| CN103238595B (en) | Special concentrated type glutaraldehyde disinfectant for endoscopes and preparation method of special concentrated type glutaraldehyde disinfectant | |
| RU2013120455A (en) | COMBINED DRUG FOR TREATMENT OF FUNGAL NAIL DISEASES | |
| RU2013124416A (en) | DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | |
| RU2008146608A (en) | HYDROPHILIC PHARMACEUTICAL COMPOSITION FOR TREATING BURNS (OPTIONS) | |
| RU2005104747A (en) | THE DRUG FOR THE TREATMENT OF POST-UNIVERSAL PURULAR-CATARAL ENDOMETRITIS AND MASTITIS IN COWS AND METHODS OF ITS APPLICATION | |
| RU2010146519A (en) | COMPOSITION OF BIOLOGICALLY ACTIVE PREPARATIONS TO INCREASE THE SURVIVAL OF STURGEON FISH IN ARTIFICIAL REPRODUCTION | |
| RU2007140808A (en) | PHARMACEUTICAL INJECTION PRODUCT BASED ON A LOW-MOLECULAR INTERFERON INDUCTOR | |
| RU2008133901A (en) | COMBINED ANTI-GLAUCOMINE MEDICINE | |
| RU2008102323A (en) | ANTIHELMINTIC DRUG FOR TREATING SMALL CATTLE | |
| RU2009112121A (en) | MEDICINE FOR THE TREATMENT OF PSORIASIS | |
| RU2010152024A (en) | DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES | |
| RU2009128857A (en) | PHARMACEUTICAL COMPOSITION OF ANTIVIRAL DRUG AND METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASES WITH THIS DRUG | |
| RU2006103299A (en) | SOLID MEDICINAL FORM OF HEPATOPROTECTIVE ACTION |